Cargando…
Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
PURPOSE: Vaccination reduces the incidence of severe COVID-19 and death and effectively limits viral spread. Concerns have been raised about COVID-19 vaccine responses in the large population of HIV-infected patients. This study aims to explore the safety and immunogenicity of the inactivated COVID-...
Autores principales: | Han, Xiaoxu, Yu, Xiaobo, Han, Ying, Fang, Qian, Shen, Congle, Liu, Hui, Wang, Peng, Wang, Yajie, Li, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037710/ https://www.ncbi.nlm.nih.gov/pubmed/35480056 http://dx.doi.org/10.2147/IDR.S353127 |
Ejemplares similares
-
Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
por: Yi, Yunyun, et al.
Publicado: (2023) -
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022) -
COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity
por: Liu, Ying, et al.
Publicado: (2021) -
Immunogenicity of COVID-19 Vaccination in People Living with HIV: Progress and Challenges
por: Song, Jin-Wen, et al.
Publicado: (2023) -
Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2022)